Anzeige
Meldung des Tages: Milliardenmarkt Drohnen: Warum dieser unterschätzte Player plötzlich im Fokus steht

Intellia Therapeutics News

Aktie
WKN:  A2AG6H ISIN:  US45826J1051 US-Symbol:  NTLA Branche:  Biotechnologie Land:  USA
13,26 $
+0,44 $
+3,43%
11,483 € 01.04.26
Depot/Watchlist
Marktkapitalisierung *
860,86 Mio. €
Streubesitz
8,59%
KGV
-2,29
Nachhaltigkeits-Score
22 %
Index-Zuordnung
-

Intellia Therapeutics News

03.03.26 - PR Newswire
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
Investors Eye Explosive Growth in Anti-​Aging Therapies as Market Targets $420B Milestone PR Newswire
06.01.26 wallstreetONLINE Redaktion
ARK Innovation: Cathie Wood: So macht sie ihr Portfolio für 2026 fit
Die US-​Starinvestorin Cathie Wood hat einiges in ihrem Fonds geändert, um sich neu für 2026 aufzustellen. Dabei gibt es einige Überraschungen. Cathie Wood baut zum Start ins ...
29.09.25 wallstreetONLINE Redaktion
US-Techs raus!: Cathie Wood setzt Milliarden auf China-Aktien
Cathie Wood rüttelt ihr Portfolio kräftig durch: ARK Invest verkauft US-​Tech-Schwergewichte und setzt über­raschend auf China-​Aktien wie Alibaba und Baidu. Anleger fragen sich ...
29.08.25 wallstreetONLINE Redaktion
Bitmine Käufe: Cathie Wood: ARK Invest setzt auf diese Krypto-Aktie
Cathie Wood hat es wieder getan: Sie stockt ihre Bestände an Bitmine-​Aktien weiter auf. Das ist aber nicht ihr einziger Kauf im Kryptosektor.Cathie Woods Investmentgesellschaft ...
23.04.25 - PR Newswire
Lawsuit for Investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced by the Shareholders Foundation
Lawsuit for Investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced by the Shareholders Foundation PR Newswire
14.04.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - NTLA
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - NTLA ...
14.04.25 - PR Newswire
Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA
Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA PR Newswire
14.04.25 - PR Newswire
NTLA Investors are Reminded of the Final Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
NTLA Investors are Reminded of the Final Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
13.04.25 - PR Newswire
NTLA Deadline: NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit
NTLA Deadline: NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire
11.04.25 - PR Newswire
Intellia Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - NTLA
Intellia Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - NTLA PR Newswire
10.04.25 - PR Newswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics PR Newswire
10.04.25 - PR Newswire
The Gross Law Firm Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NTLA
The Gross Law Firm Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NTLA PR Newswire
08.04.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - NTLA
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - NTLA ...
08.04.25 - PR Newswire
Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) Seeking Recovery for Investors - Contact Levi & Korsinsky
Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) Seeking Recovery for Investors - Contact Levi & Korsinsky PR Newswire
07.04.25 - PR Newswire
NTLA Investors are reminded of Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
NTLA Investors are reminded of Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
07.04.25 - PR Newswire
Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) - April 14, 2025 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) - April 14, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire
03.04.25 - PR Newswire
NTLA Investors Have Opportunity to Lead Intellia Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
NTLA Investors Have Opportunity to Lead Intellia Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP PR Newswire
03.04.25 - PR Newswire
Intellia Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights - NTLA
Intellia Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights - NTLA PR Newswire
02.04.25 - PR Newswire
NTLA Investors are reminded of Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
NTLA Investors are reminded of Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire

Newssuche

Videos

newspaper
01.04.26
Saisonalitäten: DAS machst Du falsch!
Viele Trader landen irgendwann bei Saisonalitäten, ziehen diesen stark fundamental basierten Ansatz ... Mehr »